Volume | 274,873 |
|
|||||
News | - | ||||||
Day High | 30.00 | Low High |
|||||
Day Low | 29.19 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Harmony Biosciences Holdings Inc | HRMY | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
29.52 | 29.19 | 30.00 | 29.35 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,930 | 274,873 | $ 29.57 | $ 8,129,014 | - | 18.6112 - 39.265 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
15:00:47 | 1 | $ 29.4851 | USD |
Harmony Biosciences Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.67B | 56.77M | - | 582.02M | 128.85M | 2.27 | 12.98 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Harmony Biosciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HRMY Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 29.54 | 30.655 | 28.75 | 29.33 | 354,254 | -0.04 | -0.14% |
1 Month | 32.82 | 34.08 | 28.63 | 30.60 | 372,557 | -3.32 | -10.12% |
3 Months | 32.08 | 35.395 | 28.63 | 31.62 | 376,261 | -2.58 | -8.04% |
6 Months | 20.13 | 35.395 | 18.79 | 29.50 | 471,716 | 9.37 | 46.55% |
1 Year | 32.40 | 39.265 | 18.6112 | 31.29 | 543,915 | -2.90 | -8.95% |
3 Years | 28.07 | 62.085 | 18.6112 | 38.75 | 518,517 | 1.43 | 5.09% |
5 Years | 36.50 | 62.085 | 18.6112 | 38.61 | 454,582 | -7.00 | -19.18% |
Harmony Biosciences Description
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. |